fusidic acid has been researched along with atorvastatin in 7 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (atorvastatin) | Trials (atorvastatin) | Recent Studies (post-2010) (atorvastatin) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 7,420 | 2,058 | 3,782 |
| Protein | Taxonomy | fusidic acid (IC50) | atorvastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0064 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0002 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0002 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0054 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 4.3 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C | 1 |
| Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C | 1 |
| Clarkson, MR; Conlon, PJ; Leavey, SF; Magee, CN; Medani, SA | 1 |
| Almond, A; Donaldson, K; Isles, C; Robertson, S; Teckchandani, S | 1 |
| Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM | 1 |
1 review(s) available for fusidic acid and atorvastatin
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
6 other study(ies) available for fusidic acid and atorvastatin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries | 2000 |
Rhabdomyolysis with atorvastatin and fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteomyelitis; Pyrroles; Rhabdomyolysis | 2008 |
Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteomyelitis; Pyrroles; Rhabdomyolysis; Severity of Illness Index | 2010 |
Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Interactions; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis | 2010 |
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections | 2013 |